investordatabase.org

Nodenza Venture Partners

nodenza.com Direct investor

Nodenza Venture Partners is a life sciences venture firm established by entrepreneurs and founders. It invests in disruptive technologies and therapies at clinical and product-launch value inflection points, and has led Series A rounds in its portfolio companies.

Nodenza Venture Partners is a venture capital firm headquartered in New York, United States. It invests directly in companies, at Series A, in life sciences, therapeutics, medical devices and biotech. 3 portfolio companies, as it reports.

“Nodenza is focused on seeking and investing in disruptive technologies and therapies with the potential to deliver exceptional benefits to patients.”

— Nodenza Venture Partners, own website
Layer
Direct investor
Type
Venture capital
Stage
Series A
Headquarters
New York, United States
Sectors
life sciences, therapeutics, medical devices, biotech
Portfolio
3 companies

Team, as Nodenza Venture Partners publishes it

  • Ross Morton Managing Partner
  • Prof. Bryan Morton CBE Chairman & Partner
  • Dr Tim Corn Partner
  • George Freeman FRSA Chairman of the Advisory Board
  • Dr Carsten Thiel Advisory Board Member
  • Paul Sekhri Advisory Board Member

Names and roles exactly as listed on nodenza.com. Nothing else about these people is recorded.

Where this comes from

Every fact above was read from a page Nodenza Venture Partners publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 20014 · added 2026-10-27 · link last verified 2026-10-27 · confidence medium

Similar investors

Listed under